CaveoVasc® – Closure Devices in the Pipeline 

CaveoVasc XL

• Covering rapidly increasing market of endovascular procedures
  (e.g. EVAR, aortic valve replacement and mitral valve surgery)

• These procedures need a big access (16F and more)

• Modification in shaft size (18 F) and additional channel for application of haemostatic agents, e.g. fibrin glue

Advantages

• Avoiding open surgery in the groin

• Procedures could be performed completely percutaneous

CaveoVenous

• Covering increasing market of electrophysiolocical procedures such as ablation, percutaneous mitral valve surgery and leadless pacemakers

• Modification in shaft size and indicator function necessary

Advantages

• Avoiding massive haematoma in the groin